Disorders of Sexual Development

119 Disorders of Sexual Development



The development of the internal and external male and female reproductive systems from early embryogenesis through puberty involves a highly complex series of genetic and hormonal influences. Differentiation between these systems occurs in early fetal life (first trimester), and the components of sexual differentiation have classically been divided into three main categories: chromosomal sex (XX vs. XY), gonadal sex (ovary vs. testis), and phenotypic sex (female vs. male reproductive organs). Abnormalities of one or more of these important developmental stages may result in a disorder of sexual development with several possible phenotypic outcomes, such as ambiguous genitalia to complete discordance between the chromosomal sex and phenotypic features.


Changes in the classification and nomenclature of these disorders have occurred in more recent years. Terms such as intersex, hermaphrodite, and pseudohermaphrodite can be perceived as derogatory and confusing when used to discuss a newborn’s abnormalities. Therefore, this terminology has been replaced with the designation disorders of sexual development (DSD), which is a broader descriptor that reflects the fact that a patient has discordance between the internal reproductive organs and external genitalia because of various mechanisms. Current categories are now considered as sex chromosome DSDs, 46,XY DSDs, and 46,XX DSDs. This chapter focuses on our current understanding of the development of internal and external reproductive organs, with a focus on the causes, evaluation, and management of the more common DSDs.



Normal Sexual Development


The normal development of the reproductive organs in humans begins with the differentiation of primordial structures and ends with the completion of secondary sexual characteristics that begins during puberty (see Chapter 67 for a discussion on puberty). Around the fifth week of gestation, the genital ridge develops into the appropriate gonads based on the chromosomal sex (XX or XY) established at conception. A complex series of genetic events must occur to establish the appropriate differentiation to an ovary or testis. It was clear that genes on the Y chromosome were involved in this differentiation because the presence of a Y chromosome resulted in male sexual characteristics, such as in XY or XXY individuals. Before these genes were known, they were referred to as “testis-determining factor” (TDF) because their presence led to testis formation. Ovaries and other female-specific reproductive organs were believed to develop by “default” because of the absence of Y chromosome material or TDF. Accordingly, research in mice and humans with X-Y translocations determined that the SRY gene (sex-determining region, Y) encoded for a transcription factor that is necessary for male reproductive organ development. Additional genes have also been identified for testis formation (Figure 119-1), and mutations in any of these genes (e.g., SOX9, DMRT1) have been associated with sex-reversal in XY patients. It is also important to note that more recent data have demonstrated an active role of several genes (FOXL2, WNT4, RSPO1) in ovary development in XX individuals, contradicting the older “default” female development notion.



After the development of the gonads, the genital ducts must differentiate into the appropriate internal structures necessary for reproduction (Figure 119-2). In the undifferentiated stage, both mesonephric (Wolffian) and paramesonephric (Müllerian) ducts are present. In males, the newly formed testes secrete anti-Müllerian hormone (AMH), inhibin B, and testosterone between weeks 7 and 11, causing the Müllerian ducts to regress and the Wolffian ducts to persist, eventually becoming the seminal vesicles, vas deferentia, and epididymis. The opposite occurs in females, in whom the absence of testicular secretions causes the mesonephric ducts to regress and the Müllerian ducts to persist, forming the fallopian tubes, uterus, and upper third of the vagina



The undifferentiated genital tubercle, labioscrotal swellings, and urethral folds are present around gestational week 4, and the external genitalia begin to become more distinguishable during weeks 9 to 13. In males, the presence of testosterone and the testosterone derivative dihydrotestosterone (converted by 5-αreductase) causes the genital tubercle to form the glans penis, stimulating the urethral folds to fuse ventrally and form the spongy urethra and resulting in part of the penile shaft and labioscrotal swellings to fuse and form the scrotum (Figure 119-3). The absence of testosterone and dihydrotestosterone in females causes the genital tubercle to form the glans clitoris and the urethral folds and labioscrotal swelling to remain unfused (except posteriorly) to form the labia minora and labia majora, respectively. In males, testicular descent begins during the twelfth week of gestation and finishes during the third trimester.




Etiology, Pathogenesis, and Clinical Presentation


Because of the myriad genes associated with urogenital development, many genetic abnormalities may alter the structure and function of the reproductive organs. As noted above, these DSDs have been recently subtyped into sex chromosome DSDs, 46,XY DSDs, and 46,XX DSDs (Table 119-1). Sex chromosome DSDs are caused by various mechanisms (Figure 119-4) and include Klinefelter syndrome (47,XXY) and variants, Turner syndrome (45,X) and variants, and other types of XX/XY mosaicism, as discussed in Chapter 118, and typically result in largely normal prenatal sexual development but reduced function of the gonads during and after puberty. Most other genetic abnormalities may include point mutations, frameshift mutations, or deletions of specific genes that cause the protein product to be nonfunctional and thereby affect gonad differentiation, leading to a disparity between the chromosomal sex (XX or XY) and gonad development (ovary or testis).


Table 119-1 Classification of Disorders of Sexual Differentiation



































































































Sex Chromosome DSDs 46,XY DSDs 46,XX DSDs
A. 47,XXY A. Disorders of testicular development A. Disorders of ovarian development
B. 45,X 1. Complete or partial gonadal dysgenesis (e.g., SRY, SOX9, SF1, WT1, DHH) 1. Gonadal dysgenesis
C. 45,X/46,XY 2. Ovotesticular DSD 2. Ovotesticular DSD
D. 46,XX/46,XY mosaicism 3. Testis regression 3. Testicular DSD (SRY+, dup SOX9)
  B. Disorders of androgen synthesis B. Androgen excess
  1. LH receptor mutations 1. Fetal (3-β hydroxysteroid dehydrogenase 2), 21-hydroxylase (CYP21A2), P450 oxidoreductase (POR), 11-β hydroxylase (CYP11B1), glucocorticoid receptor mutations
  2. Smith-Lemli-Opitz (cholesterol biosynthesis defect) 2. Fetoplacental (aromatase [CYP19], oxidoreductase [POR])
  3. Cholesterol side-chain cleavage (CYP11A1) 3. Maternal (virilizing tumors [luteoma], androgenic drugs)
  4. 17-α hydroxylase (CYP17)  
  5. P450 oxidoreductase (POR)  
  6. 5-α reductase 2  
  C. Disorders of androgen action C. Other
  1. Androgen insensitivity syndrome 1. Syndromic associations (cloacal anomalies)
  2. Drugs and environmental modulators 2. Müllerian agenesis or hypoplasia (MURCS)
    3. Uterine abnormalities (MODY5)
  D. Other 4. Vaginal atresia (McKusick-Kaufman)
  1. Syndromic associations of male genital development (cloacal anomalies, Robinow, Aarskog, hand-foot-genital) 5. Labial adhesions
  2. Persistent Müllerian duct syndrome  
  3. Vanishing testis syndrome  
  4. Isolated hypospadias  
  5. Congenital hypogonatropic hypogonadism  
  6. Cryptorchidism (INSL3, GREAT)  
  7. Environmental influences  

DSD, disorders of sexual development; LH, luteinizing hormone; MURCS, Müllerian duct aplasia, renal agenesis or ectopia, and cervical somite dysplasia; MODY5, maturity-onset diabetes of the young.


Adapted from Hughes IA: Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab 22:119-134, 2008.


< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jun 19, 2016 | Posted by in PEDIATRICS | Comments Off on Disorders of Sexual Development

Full access? Get Clinical Tree

Get Clinical Tree app for offline access